Janus Henderson Group PLC Ascendis Pharma A/S Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,427,792 shares of ASND stock, worth $909 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
4,427,792
Previous 4,486,949
1.32%
Holding current value
$909 Million
Previous $699 Million
9.28%
% of portfolio
0.39%
Previous 0.4%
Shares
25 transactions
Others Institutions Holding ASND
# of Institutions
283Shares Held
60MCall Options Held
217KPut Options Held
73.3K-
Ra Capital Management, L.P. Boston, MA10.3MShares$2.11 Billion38.78% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$1.12 Billion4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.98MShares$1.02 Billion15.67% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$874 Million1.14% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.58MShares$735 Million0.39% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $11.5B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...